Multimodal vs Symptom-Specific Treatments for Concussion
(SMART Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests different treatment options for teenagers who have had a concussion and continue to experience symptoms like dizziness, neck pain, headaches, or trouble sleeping. The trial compares a general treatment approach, Generic Concussion Treatment, which combines exercises and relaxation techniques, with more specific treatments targeting each symptom. It aims to determine which methods reduce symptoms faster and more effectively. Teens aged 13-19 who have had a concussion in the last two weeks and are experiencing moderate to severe symptoms might be suitable for this trial. As an unphased trial, this study offers a unique opportunity to explore innovative treatment options that could improve recovery outcomes for teenagers.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that the treatments under study for concussion—addressing multiple symptoms, headaches, and dizziness/neck pain—are promising in terms of safety and ease of use.
For the treatment targeting multiple symptoms, studies have found it safe and practical for individuals with post-concussion syndrome. Participants in some studies experienced symptom improvement without serious side effects.
Regarding headache-specific treatments, such as the greater occipital nerve block with Bupivacaine, sources report no safety concerns. Bupivacaine is generally well-tolerated in medical settings.
For treating dizziness and neck pain, studies on cervicovestibular physiotherapy (a combination of neck and balance exercises) suggest it is safe and commonly used in physical therapy. It helps manage symptoms like dizziness and neck pain without significant negative effects.
Overall, these treatments are designed to be safe and have been successfully used in various settings to manage concussion symptoms.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these treatments for concussion because they offer tailored, symptom-specific approaches that go beyond standard care, which often includes rest and general symptom management. The headache treatment is unique because it uses a peripheral nerve block with 0.5% Bupivacaine, which directly targets headache pain through a novel mechanism of action. The dizziness and neck pain treatment stands out by incorporating cervicovestibular physiotherapy (CV PT), which combines specialized techniques for the cervical spine and vestibular system, providing a more comprehensive approach to rehabilitation. Lastly, the multimodal treatment is distinctive as it integrates multiple therapeutic techniques such as physiotherapy, cognitive-behavioral interventions, and relaxation exercises, addressing a range of concussion symptoms in a holistic manner. These innovative approaches aim to provide more effective and personalized care for concussion patients.
What evidence suggests that this trial's treatments could be effective for concussion?
Research has shown that different treatments can effectively manage post-concussion symptoms. In this trial, participants in the headache treatment arm may receive a peripheral, greater occipital nerve block. Studies have found this treatment significantly reduces symptoms for 77% of patients, with noticeable improvements in headache and dizziness. Alternatively, participants may receive the multimodal treatment protocol, which combines therapies like physical therapy and relaxation techniques. This approach has improved symptoms such as headache and neck pain, with patients showing an average improvement of 9 points on the post-concussion symptom scale. For those in the dizziness and/or neck pain treatment arm, vestibular rehabilitation, a therapy to improve balance and reduce dizziness, has proven beneficial. These findings suggest that each treatment approach in this trial can help reduce post-concussion issues.14678
Who Is on the Research Team?
Carolyn Emery, PhD
Principal Investigator
University of Calgary
Are You a Good Fit for This Trial?
The SMART Concussion Trial is for young people aged 13-19 who've had a concussion with symptoms like headaches, dizziness, or neck pain lasting over a week but less than three weeks. They must be able to communicate in English and have access to a smartphone or computer. Those with severe brain injuries, certain medical conditions, or an inability to participate in physical activities due to reasons other than the concussion cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive symptom-specific or multimodal treatment for up to 6 weeks, including headache treatment, dizziness/neck pain treatment, or a combination of physiotherapy and cognitive-behavioral interventions.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments of symptom changes and quality of life.
Long-term Follow-up
Participants are monitored for return to unrestricted physical activity and long-term outcomes.
What Are the Treatments Tested in This Trial?
Interventions
- Generic Concussion Treatment
- Symptom-specific Dizziness &/or Neck Pain Treatment
- Symptom-specific Headache Treatment
- Symptom-specific Sleep Disturbance Treatment
Generic Concussion Treatment is already approved in United States, Canada, European Union for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Calgary
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator